Having confirmed that numerous biological agents able to diminish the levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, could potentially exhibit effectiveness in the management of gastric ulceration [108]. Here, IL1B is linked to gastric ulcer.